Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032
Overview
The Middle East & Africa Antimicrobial Susceptibilty Testing Market is expected to reach a 147.06 USD Million by 2032 and is projected to grow at a CAGR of 6.44% from 2025 to 2032.
Revenue, 2024 (USD Million)
106.14
Forecast, 2032 (USD Million)
147.06
CAGR, 2024 - 2032
6.44%
Report Coverage
Middle East & Africa
Middle East & Africa Antimicrobial Susceptibilty Testing Market 2018-2032 USD Million
Middle East & Africa Antimicrobial Susceptibilty Testing Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 106.14 USD Million
- Projected Market Size (2032): 147.06 USD Million
- CAGR (2025-2032): 6.44%
Key Findings of Middle East & Africa Antimicrobial Susceptibilty Testing Market
- The Middle East & Africa Antimicrobial Susceptibilty Testing Market was valued at 106.14 USD Million in 2024.
- The Middle East & Africa Antimicrobial Susceptibilty Testing Market is likely to grow at a CAGR of 6.44% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Anti Bacterial Testing in Type Segment accounted for the largest share of the market with a revenue of 79.00 USD Million
- The fastest growing segment Disk Diffusion in Method Segment grew Fastest with a CAGR of 8.20% during the forecast period from 2024 to 2032.
Middle East & Africa Antimicrobial Susceptibilty Testing Market Scope
Middle East & Africa Antimicrobial Susceptibilty Testing Market Segmentation & Scope
Application
- Others
- Epidemiology
- Drug Discovery and Development
- Clinical Diagnostics
Type
- Others
- Anti Fungal Testing
- Anti Bacterial Testing
Method
- Others
- Geneotypic Methods
- E-Test
- Mass Spectrometry Method
- Dilution
- Disk Diffusion
End User
- Others
- Research Centres and Academic Institutes
- Contract Research Organizations
- Pharmaceutical & Biotechnology companies
- Diagnostic Laboratories
- Hospitals
Product Type
- Service & Software
- Consumables & Accessories
- Instruments
Distribution Channel
- Third Party Distributor
- Retail Sales
- Direct Sales
Middle East & Africa Antimicrobial Susceptibilty Testing Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 106.14 USD Million |
| Market Value in 2032 | 147.06 USD Million |
| CAGR (2025-2032) | 6.44% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Application,Type,Method,End User,Product Type,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): Middle East & Africa, leading in terms of revenue 106.14 USD Million in 2024
- Key Country: South Africa, leading in terms of revenue with value of 36.67 USD Million in 2024.
Segments and Scope
-
Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032, By Application
- Clinical Diagnostics is the largest segment in Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 76.85 USD Million in the year 2024.
- Clinical Diagnostics is the Fastest growing segment in Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 6.94 % in forecast period 2025-2032.
-
Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032, By Type
- Anti Bacterial Testing is the largest segment in Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 79.00 USD Million in the year 2024.
- Anti Bacterial Testing is the Fastest growing segment in Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 6.86 % in forecast period 2025-2032.
-
Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032, By Method
- Disk Diffusion is the largest segment in Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 47.48 USD Million in the year 2024.
- Disk Diffusion is the Fastest growing segment in Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 8.20 % in forecast period 2025-2032.
-
Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032, By End User
- Hospitals is the largest segment in Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 60.15 USD Million in the year 2024.
- Diagnostic Laboratories is the Fastest growing segment in Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 6.39 % in forecast period 2025-2032.
-
Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032, By Product Type
- Instruments is the largest segment in Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 62.55 USD Million in the year 2024.
- Instruments is the Fastest growing segment in Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 7.27 % in forecast period 2025-2032.
-
Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032, By Distribution Channel
- Direct Sales is the largest segment in Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032 with a revenue of 76.91 USD Million in the year 2024.
- Direct Sales is the Fastest growing segment in Middle East & Africa Antimicrobial Susceptibilty Testing Market to 2032 with a Growth rate of 6.97 % in forecast period 2025-2032.
Middle East & Africa Antimicrobial Susceptibilty Testing Market Company Share Analysis
| Company Name |
|
||
| Merck & Co., Inc. | |||
| Mast Group Ltd. | |||
| Liofilchem S.r.l. | |||
| Thermo Fisher Scientific Inc. | |||
| Rosco Diagnostica A/S | |||
Middle East & Africa Antimicrobial Susceptibilty Testing Market Geographical Sales Distribution, 2018-2032 USD Million
Middle East & Africa Antimicrobial Susceptibilty Testing Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Middle East & Africa Antimicrobial Susceptibilty Testing Market is segmented based on Segmentation Application,Type,Method,End User,Product Type,Distribution Channel.
Middle East & Africa Antimicrobial Susceptibilty Testing Market was valued at USD 106.14(Revenue in USD Million) in 2020.
Middle East & Africa Antimicrobial Susceptibilty Testing Market is projected to grow at a CAGR of 6.44% during the forecast period of 2024 to 2032.
The Anti Bacterial Testing segment is expected to dominate the Middle East & Africa Antimicrobial Susceptibilty Testing Market, holding a largest market share of 79.00 USD Million in 2024
Coming Soon....
Middle East & Africa Antimicrobial Susceptibilty Testing Market Scope
Middle East & Africa Antimicrobial Susceptibilty Testing Market Segmentation & Scope
Application
- Others
- Epidemiology
- Drug Discovery and Development
- Clinical Diagnostics
Type
- Others
- Anti Fungal Testing
- Anti Bacterial Testing
Method
- Others
- Geneotypic Methods
- E-Test
- Mass Spectrometry Method
- Dilution
- Disk Diffusion
End User
- Others
- Research Centres and Academic Institutes
- Contract Research Organizations
- Pharmaceutical & Biotechnology companies
- Diagnostic Laboratories
- Hospitals
Product Type
- Service & Software
- Consumables & Accessories
- Instruments
Distribution Channel
- Third Party Distributor
- Retail Sales
- Direct Sales
Frequently Asked Questions
The Middle East & Africa Antimicrobial Susceptibilty Testing Market is segmented based on Segmentation Application,Type,Method,End User,Product Type,Distribution Channel.
Middle East & Africa Antimicrobial Susceptibilty Testing Market was valued at USD 106.14(Revenue in USD Million) in 2020.
Middle East & Africa Antimicrobial Susceptibilty Testing Market is projected to grow at a CAGR of 6.44% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Antimicrobial Susceptibilty Testing Market for final year is USD 147.06 (USD Million).
Middle East & Africa Antimicrobial Susceptibilty Testing Market Company Profiling
Frequently Asked Questions
The Middle East & Africa Antimicrobial Susceptibilty Testing Market is segmented based on Segmentation Application,Type,Method,End User,Product Type,Distribution Channel.
Middle East & Africa Antimicrobial Susceptibilty Testing Market was valued at USD 106.14(Revenue in USD Million) in 2020.
Middle East & Africa Antimicrobial Susceptibilty Testing Market is projected to grow at a CAGR of 6.44% during the forecast period of 2024 to 2032.
The estimated market value of the Middle East & Africa Antimicrobial Susceptibilty Testing Market for final year is USD 147.06 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.